Government,
Bankruptcy
Oct. 16, 2020
25 states oppose tentative Purdue Pharma bankruptcy deal
Part of the deal would preserve Purdue’s OxyContin business as a public trust so it can meet obligations such as paying its liabilities to states and other plaintiffs and delivering treatments for opioid addiction.
Xavier Becerra joined 24 other state attorneys general in a letter to U.S. Attorney General William Barr on Wednesday asking him to change a key provision of a bankruptcy settlement with Purdue Pharma LP.
Their message: States don't want to run the company's business of manufacturing pharmaceutical drugs or paying off its obligations.
Purdue filed for bankruptcy last year as part of an effort to se...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In